[HTML][HTML] Recent advances progress of targeted drugs combined with radiotherapy for advanced non-small cell lung cancer: a review
J Xu, Z Wang - Frontiers in Oncology, 2023 - ncbi.nlm.nih.gov
Targeted drug therapy plays an important role in the clinical application of non-small cell
lung cancer, especially adenocarcinoma. However, for patients with advanced disease, drug …
lung cancer, especially adenocarcinoma. However, for patients with advanced disease, drug …
[HTML][HTML] Radiation Recall Pneumonitis: The Open Challenge in Differential Diagnosis of Pneumonia Induced by Oncological Treatments
The treatment of primary and secondary lung neoplasms now sees the fundamental role of
radiotherapy, associated with surgery and systemic therapies. The improvement in survival …
radiotherapy, associated with surgery and systemic therapies. The improvement in survival …
[HTML][HTML] Dacomitinib in EGFR-mutant non-small-cell lung cancer with brain metastasis: a single-arm, phase II study
HA Jung, S Park, SH Lee, JS Ahn, MJ Ahn, JM Sun - ESMO open, 2023 - Elsevier
Introduction Dacomitinib showed superior progression-free survival (PFS) and overall
survival compared to gefitinib in patients with advanced non-small-cell lung cancer (NSCLC) …
survival compared to gefitinib in patients with advanced non-small-cell lung cancer (NSCLC) …